fluoxetine and pituitrin

fluoxetine has been researched along with pituitrin in 15 studies

Research

Studies (15)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (6.67)	18.7374
1990's	9 (60.00)	18.2507
2000's	2 (13.33)	29.6817
2010's	3 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Pavel, S	1
Baylis, PH; Faull, CM; Rooke, P	1
Battaglia, G; Brownfield, MS; Cabrera, TM; Levy, AD; Li, Q; Van de Kar, LD	1
Ahmed, I; Aravich, PF; Lauterio, TJ; Rieg, TS	1
Battaglia, G; Brownfield, MS; Cabrera, TM; Levy, AD; Li, Q; Rittenhouse, PA; van de Kar, LD	1
Ferris, CF	1
Brownfield, MS; Levy, AD; Li, Q; Murakami, I; Nichols, DE; Stall, S; Van de Kar, LD	1
Bonmarchand, G; Chevron, V; Droy, JM; Girault, C; Goullé, JP; Leroy, J; Richard, JC	1
Ayonrinde, OT; Sanfilippo, FM	1
Amico, JA; Marar, IE	1
Dinan, TG; Scott, LV	1
Jørgensen, H; Kjaer, A; Knigge, U; Møller, M; Warberg, J	1
Melloni, RH; Ricci, LA	2
Rubin, DH; Walkup, JT	1

Reviews

1 review(s) available for fluoxetine and pituitrin

Article	Year
Vasopressin as a target for antidepressant development: an assessment of the available evidence. Journal of affective disorders, 2002, Volume: 72, Issue:2 Topics: Adrenocorticotropic Hormone; Antidepressive Agents; Corticotropin-Releasing Hormone; Depressive Disorder, Major; Fluoxetine; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Pituitary-Adrenal System; Receptors, Vasopressin; Vasopressins	2002

Article

Year

Vasopressin as a target for antidepressant development: an assessment of the available evidence.

Journal of affective disorders, 2002, Volume: 72, Issue:2

Topics: Adrenocorticotropic Hormone; Antidepressive Agents; Corticotropin-Releasing Hormone; Depressive Disorder, Major; Fluoxetine; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Pituitary-Adrenal System; Receptors, Vasopressin; Vasopressins

2002

Trials

1 trial(s) available for fluoxetine and pituitrin

Article	Year
The effect of a highly specific serotonin agonist on osmoregulated vasopressin secretion in healthy man. Clinical endocrinology, 1991, Volume: 35, Issue:5 Topics: Adolescent; Adult; Body Water; Double-Blind Method; Fluoxetine; Humans; Male; Osmolar Concentration; Sodium; Urine; Vasopressins; Water-Electrolyte Balance	1991

Other Studies

13 other study(ies) available for fluoxetine and pituitrin

Article	Year
The mechanism of action of vasotocin in the mammalian brain. Progress in brain research, 1979, Volume: 52 Topics: Animals; Cats; Fluoxetine; Humans; Hypothalamus; Injections, Intraventricular; Luteinizing Hormone; Male; Melatonin; Neurons; Oxytocin; Pineal Gland; Prolactin; Rats; Serotonin; Sleep; Time Factors; Vasopressins; Vasotocin	1979
Attenuation of hormone responses to the 5-HT1A agonist ipsapirone by long-term treatment with fluoxetine, but not desipramine, in male rats. Biological psychiatry, 1994, Sep-01, Volume: 36, Issue:5 Topics: Adrenocorticotropic Hormone; Animals; Anti-Anxiety Agents; Brain; Desipramine; Dose-Response Relationship, Drug; Fluoxetine; Hormones; Male; Oxytocin; Prolactin; Pyrimidines; Rats; Rats, Wistar; Receptors, Serotonin; Renin; Vasopressins	1994
Fluoxetine induces vasopressin and oxytocin abnormalities in food-restricted rats given voluntary exercise: relationship to anorexia nervosa. Brain research, 1993, May-28, Volume: 612, Issue:1-2 Topics: Animals; Anorexia Nervosa; Behavior, Animal; Body Weight; Dynorphins; Eating; Fluoxetine; Male; Oxytocin; Physical Conditioning, Animal; Rats; Rats, Sprague-Dawley; Suprachiasmatic Nucleus; Supraoptic Nucleus; Vagus Nerve; Vasopressins	1993
Long-term treatment with the antidepressants fluoxetine and desipramine potentiates endocrine responses to the serotonin agonists 6-chloro-2-[1-piperazinyl]-pyrazine (MK-212) and (+-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane HCl (DOI). The Journal of pharmacology and experimental therapeutics, 1993, Volume: 266, Issue:2 Topics: Adrenocorticotropic Hormone; Amphetamines; Animals; Desipramine; Drug Synergism; Fluoxetine; Hormones; Ketanserin; Male; Pyrazines; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists; Vasopressins	1993
Serotonin diminishes aggression by suppressing the activity of the vasopressin system. Annals of the New York Academy of Sciences, 1996, Sep-20, Volume: 794 Topics: Aggression; Animals; Behavior, Animal; Cricetinae; Fluoxetine; Male; Serotonin; Time Factors; Vasopressins	1996
Neuroendocrine pharmacology of three serotonin releasers: 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butane (MBDB), 5-methoxy-6-methyl-2-aminoindan (MMAi) and p-methylthioamphetamine (MTA). The Journal of pharmacology and experimental therapeutics, 1996, Volume: 279, Issue:3 Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Fluoxetine; Indans; Male; Oxytocin; Prolactin; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Vasopressins	1996
Syndrome of inappropriate secretion of antidiuretic hormone in two elderly women with elevated serum fluoxetine. Journal of toxicology. Clinical toxicology, 1997, Volume: 35, Issue:1 Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Contraindications; Female; Fluoxetine; Humans; Hyponatremia; Inappropriate ADH Syndrome; Vasopressins	1997
SSRI antidepressants and SIADH. The Australian and New Zealand journal of psychiatry, 1997, Volume: 31, Issue:2 Topics: Aged; Female; Fluoxetine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Vasopressins	1997
Vasopressin, oxytocin, corticotrophin-releasing factor, and sodium responses during fluoxetine administration in the rat. Endocrine, 1998, Volume: 8, Issue:1 Topics: Animals; Corticotropin-Releasing Hormone; Drinking; Fluoxetine; Gene Expression; In Situ Hybridization; Male; Oxytocin; Paraventricular Hypothalamic Nucleus; Pituitary Gland; Rats; Rats, Sprague-Dawley; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Sodium; Supraoptic Nucleus; Vasopressins	1998
Serotonin stimulates hypothalamic mRNA expression and local release of neurohypophysial peptides. Journal of neuroendocrinology, 2003, Volume: 15, Issue:6 Topics: Animals; Corticotropin-Releasing Hormone; Fluoxetine; Gene Expression Regulation; Male; Oxytocin; Paraventricular Hypothalamic Nucleus; Rats; Rats, Wistar; Receptors, Serotonin; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Receptor Agonists; Supraoptic Nucleus; Vasopressins	2003
Repeated fluoxetine administration during adolescence stimulates aggressive behavior and alters serotonin and vasopressin neural development in hamsters. Behavioral neuroscience, 2012, Volume: 126, Issue:5 Topics: Aggression; Animals; Behavior, Animal; Brain; Cricetinae; Fluoxetine; Neurons; Selective Serotonin Reuptake Inhibitors; Serotonin; Vasopressins	2012
SSRIs, adolescents, and aggression: tempering human implications regarding SSRI-induced aggression in hamsters: comment on Ricci and Melloni (2012). Behavioral neuroscience, 2012, Volume: 126, Issue:5 Topics: Aggression; Animals; Fluoxetine; Neurons; Selective Serotonin Reuptake Inhibitors; Serotonin; Vasopressins	2012
Preclinical investigations into the relationship between adolescent SSRI exposure and aggressive behavior: response to commentary by Rubin and Walkup (2012). Behavioral neuroscience, 2013, Volume: 127, Issue:1 Topics: Aggression; Animals; Fluoxetine; Neurons; Selective Serotonin Reuptake Inhibitors; Serotonin; Vasopressins	2013